Harmony Biosciences Holdings (HRMY) Short-term Investments (2022 - 2026)

Harmony Biosciences Holdings has disclosed Short-term Investments across 5 years of filings, most recently posting $51.5 million for Q1 2026.

• Short-term Investments for Q1 2026 came in at $51.5 million, up 186.94% year-over-year; the trailing twelve-month figure through Mar 2026 was $51.5 million (up 186.94% YoY), and the FY2025 annual result was $22.8 million, up 61.0% from the prior year.
• Short-term Investments came in at $51.5 million for Q1 2026 at Harmony Biosciences Holdings, up from $22.8 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $79.3 million in Q4 2022 to a low of $14.2 million in Q4 2024.
• The 5-year median for Short-term Investments is $34.5 million (2024), against an average of $36.5 million.
• Across the five-year window, Short-term Investments jumped 203.71% in 2023 and tumbled 66.06% in 2024, its largest moves.
• Harmony Biosciences Holdings' Short-term Investments stood at $79.3 million in 2022, then sank by 47.31% to $41.8 million in 2023, then sank by 66.06% to $14.2 million in 2024, then jumped by 61.0% to $22.8 million in 2025, then soared by 125.59% to $51.5 million in 2026.
• The last three Short-term Investments figures came in at $51.5 million (Q1 2026), $22.8 million (Q4 2025), and $25.6 million (Q3 2025), per Business Quant data.